Recent Development in Clinical Trial

Organizer:  Ivan S. F. Chan (Merck Research Laboratories, Pennsylvania, U.S.A. )

and Chin-Fu Hsiao (National Health Research Institutes, Taiwan, R.O.C.)

Email:   ivan_chan@merck.com and chinfu@nhri.org.tw

Chair: Ivan S. F. Chan (Merck Research Laboratories, Pennsylvania, U.S.A. )

Email: ivan_chan@merck.com

Mei-Chiung Shih

Health Research and Policy-Biostatistics, Stanford University, U.S.A.

Email:  meichiun@stanford.edu

Title: Designed Extension of Survival Studies:  Application to Clinical Trials with Unrecognized Heterogeneity

Weichung Joe Shih

University of Medicine & Dentistry of New Jersey, USA

Email: shihwj@umdnj.edu

Title: Estimating Survival Curve With Unlinked Entry and Failure Times

Hsiao Hui Tsou

National Health Research Institutes, Taiwan, R.O.C.

Email: tsouhh@nhri.org.tw

Title: Mixed Non-inferiority Margin and Statistical Tests in Active Controlled Trials

J. Jack Lee

University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

Email:  jjlee@mdanderson.org

Title: Adaptive Randomization for Personalized Medicine in Cancer Clinical Trials

Xiaoping Xiong

St. Jude Children's Research Hospital Memphis, Tennessee, USA

Email:  xiaoping.xiong@stjude.org

Title: Sequential Conditional Probability Ratio Test: An Ideal Design for Clinical Trials?